Navigation Links
Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
Date:8/19/2010

NEW YORK, Aug. 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED

http://www.reportlinker.com/p0265199/Advances-in-Large-Scale-BioManufacturing-and-Scale-Up-Production-2nd-ED.html

A Comprehensive Study of the Science, Technology and Business of Biopharmaceutical Manufacturing. This new ASM study provides a clear view of what the industry perceives to be the future of biopharmaceutical manufacturing.  

Chapter Abstracts Index:

Frontiers in Bioprocessing: 2007

The Science for Biogenerics: Are We There Already?

Maximizing Productivity in Biopharmaceutical Manufacturing

Increasing Performance of Mammalian Expression Platforms

Cell Line Engineering and Development: Case Studies

Design of Large-Scale Cell Culture Process

Challenges in Biopharmaceutical Scale-up to Production

Large-Scale Microbial Production Technology for Human Therapeutic Products

Microbiological Methods in Support of Manufacturing

Initial Protein Recovery Process

The Scaling Up of Fermentation and Primary Recovery Processes of Soluble Protein Antigens

Scale-up of Saccharomyces cerevisiae Fermentation

Good Automation Manufacturing Practice (GAMP)

Advances in Improved Expression of Recombinant Proteins in Microbial Systems

Design of Large-Scale Cell Culture Process —A Process Engineering Point of View

Protein Stability, Solubility and Solute Interactions

Launching New Biologics: A Process and Facility Design Approach

Disposable Technologies for Manufacturing of Biologics

Managing Large Volume, Single Use Disposables

Optimization of Antibody Processing: Upstream and Downstream

Simulated Moving Bed Chromatography

Implementation of Membrane Technology in Antibody Large-Scale Purification

Development of Viral Clearance Strategies for Large-Scale Monoclonal Antibody Production

Downstream Processing: Removing Economic and Technical Bottlenecks

Purification of Monoclonal and Genetically Engineered Antibodies

Regulatory Environment for Follow-on Biologics

Post-Approval Changes for Large Scale Biopharmaceutical Manufacturing: Global

FDA and Regulatory Issues in Biopharmaceutical Manufacturing

Strategic Issues: Capital Investments

Pricing Issues for Biotechnology Products

Economics of Scheduling, De-bottlenecking, and Cycle Time

Intellectual Property Considerations in Scale-Up of Biomanufacturing Processes

Forecasting Industry-wide Biopharmaceutical Manufacturing Capacity Requirements

Worldwide Therapeutic Protein Production Capacity

Authors and Reviewers:

Accelsiors Group International

Advanced Scientifics Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Biogen IDEC

Biomanufacturing Training and Education Center

BioPharm Services UK

BioProcess Technology

Biotechnology Unit, NIDDK, NIH

Bristol Myers Squibb

Chromos, Burnaby, BC

Cambrex Bio Science

Clonex Development, Inc.

Consultants Inc.

Eli Lilly & Co.

Eli Lilly & Co.

Eli Lilly & Co.

Eli Lilly & Co.

Falconridge Associates

Fluor Corporation/Fluor Daniel Inc.

Fluor Corporation/Fluor Daniel Inc.

Fluor Corporation/Fluor Daniel Inc.

GE Healthcare

Human Genome Sciences

Institute for Chemical and Bioengineering

Intelligen, Inc.

Johns Hopkins University

Magneticals

Max Planck Institute

Medical Marketing Economics, LLC

Medimmune

Merck & Co., Inc.

Merck Research Laboratories

Merck Research Laboratories

Morphotek

NC State University

ncBIOsource

Newport Biotech Consultants

Newport Consulting

Novavax Inc

Novozymes Delta Limited

PD-Direct Services

Protein Sciences Corp

SAIC, National Cancer Institute

Sanofi Pasteur

Sartorius AG, Germany

Schwegman Lundberg Woessner & Kluth

Scios Inc.

Seattle Genetics

Strategic Manufacturing Worldwide, Inc.

TLG Consulting Inc.

Universite Clermont

Vectech Pharmaceutical Consultants, Inc.

To order this report:Biopharmaceutical Industry: Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED

Biopharmaceutical Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact Nicolas Bombourg: nbo@reportlinker.comUS: (805)-652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):